2011•Chinese Journal of Clinical Rational Drug UseRequires access

Effect observation of Trimetazidine in treatment of ischemic heart failure

Wang Guo-an

Open publisher page 0 citations

Abstract

Objective To observe the effect of Trimetazidine in treatment of ischemic heart failure. Methods 90 cases of ischemic heart failure were randomly divided into observation group and control group(45 cases in each) . Both groups received conventional treatment,and observation group received trimetazidine based on the control group,before and after treatment,left ventricular ejection fraction(LVEF) and left ventricular end-diastolic diameter(LVEDD) changes were observed,and the clinical efficacy was compared.Results After treatment,LVEDD decreased and LVEF increased in both groups and the differences were significant(P0.05) ,but the improvement in the observation group was better than that in the control group,and the differences were statistically significant(P0.05) . The total effective rate in the observation group was 91.1%,which was higher than 71.1% in the control group,and the difference was statistically significant(P0.05) .Conclusion Trimetazidine in treatment of ischemic heart failure is safe and effective.

About this research paper

What this paper is about

Objective To observe the effect of Trimetazidine in treatment of ischemic heart failure. Methods 90 cases of ischemic heart failure were randomly divided into observation group and control group(45 cases in each) . Both groups received conventional treatment,and observation group received trimetazidine based on the control group,before and after treatment,left ventricular ejection fraction(LVEF) and left ventricular end-diastolic diameter(LVEDD) changes were observed,and the clinical efficacy was compared.Results After treatment,LVEDD decreased and LVEF increased in both groups and the differences were significant(P0.05) ,but the improvement in the observation group was better than that in the control group,and the differences were statistically significant(P0.05) . The total effective rate in the observation group was 91.1%,which was higher than 71.1% in the control group,and the difference was statistically significant(P0.05) .Conclusion Trimetazidine in treatment of ischemic heart failure is safe and effective.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effect of Trimetazidine in treatment of ischemic heart failure. Methods 90 cases of ischemic heart failure were randomly divided into observation group and control group(45 cases in each) . Both groups received conventional treatment,and observation group received trimetazidine based on the control group,before and after treatment,left ventricular ejection fraction(LVEF) and left ventricular end-diastolic diameter(LVEDD) changes were observed,and the clinical efficacy was compared.Results After treatment,LVEDD decreased and LVEF increased in both groups and the differences were significant(P0.05) ,but the improvement in the observation group was better than that in the control group,and the differences were statistically significant(P0.05) . The total effective rate in the observation group was 91.1%,which was higher than 71.1% in the control group,and the difference was statistically significant(P0.05) .Conclusion Trimetazidine in treatment of ischemic heart failure is safe and effective.

Key concepts: Trimetazidine, Medicine, Ejection fraction, Cardiology, Heart failure, Internal medicine, Conventional treatment, Diastole

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect observation of Trimetazidine in treatment of ischemic heart failure — Research Paper | ScholarLens